Cancer
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.
Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber ER, McDonald HA, Potter DM, Hamilton RL, Lotze MT, Khan SA, Sobol
RW, Okada H.
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10746-51.
Increased microRNA activity in human cancers.
Israel A, Sharan R, Ruppin E, Galun E.
PLoS One. 2009 Jun 25;4(6):e6045.
Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of
diffuse large B-cell lymphoma.
Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC, Robetorye RS, Aguiar RC.
Blood. 2009 Jun 25;113(26):6681-90.
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.
Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, Azab F, Runnels J, Jia X, Ngo HT, Melhem MR, Lin CP, Ribatti D, Rollins BJ,
Witzig TE, Anderson KC, Ghobrial IM.
Blood. 2009 Jun 25;113(26):6669-80.
The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells.
Kato M, Paranjape T, Ullrich R, Nallur S, Gillespie E, Keane K, Esquela-Kerscher A, Weidhaas JB, Slack FJ.
Oncogene. 2009 Jun 25;28(25):2419-24.
Systematic validation of predicted microRNAs for cyclin D1.
Jiang Q, Feng MG, Mo YY.
BMC Cancer. 2009 Jun 18;9:194.
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting
directly DNMT3A and 3B and indirectly DNMT1.
Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush
LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G.
Blood. 2009 Jun 18;113(25):6411-8.
p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia.
di Val Cervo PR, Tucci P, Majid A, Lena MA, Agostini M, Bernardini S, Candi E, Cohen G, Nicotera P, Dyer MJ, Melino G.
Blood. 2009 Jun 18;113(25):6498-9
Down-regulated miR-9 and miR-433 in human gastric carcinoma.
Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J, Nie N, Liu B, Wu X.
J Exp Clin Cancer Res. 2009 Jun 16;28:82.
Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.
Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, Fujita S, Mizutani T, Furukawa C, Fujishiro M, Ichinose M,
Shiogama K, Tsutsumi Y, Omata M, Iba H.
Clin Cancer Res. 2009 Jun 15;15(12):4009-16.
MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E.
Clin Cancer Res. 2009 Jun 15;15(12):3998-4008.
Cancer DNA methylation: molecular mechanisms and clinical implications.
McCabe MT, Brandes JC, Vertino PM.
Clin Cancer Res. 2009 Jun 15;15(12):3927-37.
let-7 microRNA reduces tumor growth.
Slack F.
Cell Cycle. 2009 Jun 15;8(12):1823.
MicroRNAs: an important player in maintaining a balance between inflammation and tumor suppression.
Bhaumik D, Patil CK, Campisi J.
Cell Cycle. 2009 Jun 15;8(12):1822.
MicroRNAs in solid tumors.
Dillhoff M, Wojcik SE, Bloomston M.
J Surg Res. 2009 Jun 15;154(2):349-54.
Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland.
Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, Clark J, Gamble J, Tran N.
Int J Cancer. 2009 Jun 15;124(12):2855-63.
Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells.
Chhabra R, Adlakha YK, Hariharan M, Scaria V, Saini N.
PLoS One. 2009 Jun 9;4(6):e5848.
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
Li T, Li D, Sha J, Sun P, Huang Y.
Biochem Biophys Res Commun. 2009 Jun 5;383(3):280-5.
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.
O'Hara AJ, Wang L, Dezube BJ, Harrington WJ Jr, Damania B, Dittmer DP.
Blood. 2009 Jun 4;113(23):5938-41.
[Effects of RNA interference silencing RhoC gene upon paclitaxel sensitivity in ovarian cancer cell lines]
Pan Y, Zhang WY, Zou JY, Sheng MJ, Xuan LL, Hai DY.
Zhonghua Yi Xue Za Zhi. 2009 Jun 2;89(21):1498-501.
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K,
Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF.
Cancer Res. 2009 Jun 1;69(11):4851-60.
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo.
Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC.
Genes Dev. 2009 Jun 1;23(11):1327-37.
[Silencing of COX-2 in nasopharyngeal carcinoma cells with a shRNAmir lentivirus vector]
Li G, Li XP, Jiang L, Lu J, Liu X, Chen SJ.
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jun;29(6):1111-4.
The impact of gene profiling in chronic myeloid leukaemia.
Yong AS, Melo JV.
Best Pract Res Clin Haematol. 2009 Jun;22(2):181-90.
Gene expression profiling in chronic lymphocytic leukaemia.
Codony C, Crespo M, Abrisqueta P, Montserrat E, Bosch F.
Best Pract Res Clin Haematol. 2009 Jun;22(2):211-22.
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.
Marcucci G, Mrózek K, Radmacher MD, Bloomfield CD, Croce CM.
Best Pract Res Clin Haematol. 2009 Jun;22(2):239-48.
Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy.
Wang QZ, Xu W, Habib N, Xu R.
Curr Cancer Drug Targets. 2009 Jun;9(4):572-94.
Driving in the melanoma landscape.
Herlyn M.
Exp Dermatol. 2009 Jun;18(6):506-8.
MicroRNAs and cancer--new paradigms in molecular oncology.
Negrini M, Nicoloso MS, Calin GA.
Curr Opin Cell Biol. 2009 Jun;21(3):470-9.
MicroRNAs are significantly influenced by p53 and radiation in HCT116 human colon carcinoma cells.
Shin S, Cha HJ, Lee EM, Jung JH, Lee SJ, Park IC, Jin YW, An S.
Int J Oncol. 2009 Jun;34(6):1645-52.
Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.
Zhang C, Kang C, You Y, Pu P, Yang W, Zhao P, Wang G, Zhang A, Jia Z, Han L, Jiang H.
Int J Oncol. 2009 Jun;34(6):1653-60.
Identification of ionizing radiation-responsive microRNAs in the IM9 human B lymphoblastic cell line.
Cha HJ, Shin S, Yoo H, Lee EM, Bae S, Yang KH, Lee SJ, Park IC, Jin YW, An S.
Int J Oncol. 2009 Jun;34(6):1661-8.
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.
Cortez MA, Calin GA.
Expert Opin Biol Ther. 2009 Jun;9(6):703-711.
Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR.
Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, Harata K, Tanaka T, Fujii Y.
Med Mol Morphol. 2009 Jun;42(2):102-9.
Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid
carcinoma.
Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW.
Horm Metab Res. 2009 Jun;41(6):482-7.
Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW.
Horm Metab Res. 2009 Jun;41(6):475-81.
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
FEBS J. 2009 Jun;276(11):2966-82.
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B, Malcikova J, Stano Kozubik K, Smardova J, Brychtova Y, Doubek M, Trbusek M,
Mayer J, Pospisilova S.
Leukemia. 2009 Jun;23(6):1159-63.
Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis.
Sekine S, Ogawa R, Ito R, Hiraoka N, McManus MT, Kanai Y, Hebrok M.
Gastroenterology. 2009 Jun;136(7):2304-2315.e1-4.
The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.
Tsang WP, Kwok TT.
Carcinogenesis. 2009 Jun;30(6):953-9.
Epigenetic mechanisms in glioblastoma multiforme.
Nagarajan RP, Costello JF.
Semin Cancer Biol. 2009 Jun;19(3):188-97.
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a
methyl-deficient diet.
Tryndyak VP, Ross SA, Beland FA, Pogribny IP.
Mol Carcinog. 2009 Jun;48(6):479-87.
MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M, Guo N.
Cancer Treat Rev. 2009 Jun;35(4):328-34.
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
Pan YZ, Morris ME, Yu AM.
Mol Pharmacol. 2009 Jun;75(6):1374-9.
Oncogenic role of microRNAs in brain tumors.
Pang JC, Kwok WK, Chen Z, Ng HK.
Acta Neuropathol. 2009 Jun;117(6):599-611.
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic
imbalances and gene expression profiles.
Lionetti M, Agnelli L, Mosca L, Fabris S, Andronache A, Todoerti K, Ronchetti D, Deliliers GL, Neri A.
Genes Chromosomes Cancer. 2009 Jun;48(6):521-31.
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and
invasive carcinoma.
Qi L, Bart J, Tan LP, Platteel I, Sluis T, Huitema S, Harms G, Fu L, Hollema H, Berg A.
BMC Cancer. 2009 May 28;9:163.
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.
Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE,
Lee YK, Mukhopadhyay D, Kay NE.
Blood. 2009 May 28;113(22):5568-74.
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk
stratification.
Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P, Bron D, Lagneaux L.
Blood. 2009 May 21;113(21):5237-45.
miRs: fine-tuning prognosis in CLL.
Sampath D, Calin GA.
Blood. 2009 May 21;113(21):5035-6.
[Expression of microRNAs in endometrioid adenocarcinoma]
Liu X, Xia W, Dai YM, Shao NS, Zhang WY.
Zhonghua Yi Xue Za Zhi. 2009 May 19;89(19):1365-7.
Molecular classification of solid tumours: towards pathway-driven therapeutics.
Swanton C, Caldas C.
Br J Cancer. 2009 May 19;100(10):1517-22.
p63 regulation by microRNAs.
Blandino G, Moll UM.
Cell Cycle. 2009 May 15;8(10):1466-7.
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute
lymphoblastic leukemia.
Agirre X, Vilas-Zornoza A, Jiménez-Velasco A, Martin-Subero JI, Cordeu L, Gárate L, San José-Eneriz E, Abizanda G, Rodríguez-Otero
P, Fortes P, Rifón J, Bandrés E, Calasanz MJ, Martín V, Heiniger A, Torres A, Siebert R, Román-Gomez J, Prósper F.
Cancer Res. 2009 May 15;69(10):4443-53.
DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic
field defect.
Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M, Sugiyama T, Ushijima T.
Int J Cancer. 2009 May 15;124(10):2367-74.
Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.
Bellon M, Lepelletier Y, Hermine O, Nicot C.
Blood. 2009 May 14;113(20):4914-7.
The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster.
Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, Wen YM, Wang CM, Yi XZ.
J Exp Clin Cancer Res. 2009 May 13;28:64.
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S, Ge R, Jiang S, Li G, Chen Y, He ML, Kung HF, Lai L, Lin MC.
Brain Res. 2009 May 7;1269:158-65.
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells.
Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, Moehler M, Gockel I.
World J Gastroenterol. 2009 May 7;15(17):2089-96.
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
Chayka O, Corvetta D, Dews M, Caccamo AE, Piotrowska I, Santilli G, Gibson S, Sebire NJ, Himoudi N, Hogarty MD, Anderson J,
Bettuzzi S, Thomas-Tikhonenko A, Sala A.
J Natl Cancer Inst. 2009 May 6;101(9):663-77.
SnapShot: MicroRNAs in Cancer.
Spizzo R, Nicoloso MS, Croce CM, Calin GA.
Cell. 2009 May 1;137(3):586-586.e1.
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade
carcinomas.
Kuo KT, Guan B, Feng Y, Mao TL, Chen X, Jinawath N, Wang Y, Kurman RJ, Shih IeM, Wang TL.
Cancer Res. 2009 May 1;69(9):4036-42.
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS.
Clin Cancer Res. 2009 May 1;15(9):2988-94.
MiR-34a and p53.
Hermeking H.
Cell Cycle. 2009 May 1;8(9):1308.
p53 and c-myc: how does the cell balance "yin" and "yang"?
Sachdeva M, Mo YY.
Cell Cycle. 2009 May 1;8(9):1303.
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.
Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V.
Exp Cell Res. 2009 May 1;315(8):1439-47.
MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and
metastasis, and frequent homozygous losses of miR-31.
Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, Månsson W, Rovira C,
Höglund M.
Int J Cancer. 2009 May 1;124(9):2236-42.
MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in
tongue squamous cell carcinoma cell lines.
Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H, Zhou X.
Cancer Genomics Proteomics. 2009 May-Jun;6(3):131-9.
MicroRNAs and their potential for translation in prostate cancer.
DeVere White RW, Vinall RL, Tepper CG, Shi XB.
Urol Oncol. 2009 May-Jun;27(3):307-11.
MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM, Green AR, Powe DG, Ellis IO.
J Clin Pathol. 2009 May;62(5):422-8.
Genetic variation of miRNA sequence in pancreatic cancer.
Zhu Z, Gao W, Qian Z, Miao Y.
Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):407-13.
[miRNAs in cancer: the case of liver tumors]
Ladeiro Y, Zucman-Rossi J.
Med Sci (Paris). 2009 May;25(5):467-72.
miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.
Flavin R, Smyth P, Barrett C, Russell S, Wen H, Wei J, Laios A, O'Toole S, Ring M, Denning K, Li J, Aherne S, Sammarae D, Aziz NA,
Alhadi A, Finn SP, Loda M, B S, Sheils O, O'Leary JJ.
Int J Gynecol Cancer. 2009 May;19(4):641-7.
miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue.
Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, Ang KK, Story MD.
Head Neck. 2009 May;31(5):642-54.
The role of microRNAs in metastasis and epithelial-mesenchymal transition.
Bracken CP, Gregory PA, Khew-Goodall Y, Goodall GJ.
Cell Mol Life Sci. 2009 May;66(10):1682-99.
miR-145 inhibits breast cancer cell growth through RTKN.
Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng L, Zhou H, Zhao RC.
Int J Oncol. 2009 May;34(5):1461-6.
Emerging functions of microRNAs in glioblastoma.
Lawler S, Chiocca EA.
J Neurooncol. 2009 May;92(3):297-306.
Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy.
Lawrie CH, Cooper CD, Ballabio E, Chi J, Tramonti D, Hatton CS.
Br J Haematol. 2009 May;145(4):545-8.
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM.
Nucleic Acids Res. 2009 May;37(8):2584-95.
A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic
differentiation of acute promyelocytic leukemia cells.
De Marchis ML, Ballarino M, Salvatori B, Puzzolo MC, Bozzoni I, Fatica A.
Leukemia. 2009 May;23(5):856-62.
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of
metalloproteinase 3.
Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, Hamilton JP, Abraham J, Georgiades C, Alvarez
H, Vivekanandan P, Yu W, Maitra A, Torbenson M, Thuluvath PJ, Gores GJ, LaRusso NF, Hruban R, Meltzer SJ.
Hepatology. 2009 May;49(5):1595-601.
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP.
Hepatology. 2009 May;49(5):1571-82.
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in
esophagus.
Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG,
Hofstetter WL, Rashid A, Luthra R.
Am J Pathol. 2009 May;174(5):1940-8.
miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells.
Lal A, Pan Y, Navarro F, Dykxhoorn DM, Moreau L, Meire E, Bentwich Z, Lieberman J, Chowdhury D.
Nat Struct Mol Biol. 2009 May;16(5):492-8.
CCR1 knockdown suppresses human non-small cell lung cancer cell invasion.
Wang CL, Sun BS, Tang Y, Zhuang HQ, Cao WZ.
J Cancer Res Clin Oncol. 2009 May;135(5):695-701.
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, Selaru FM, Hamilton JP, Yang J, Abraham
JM, Mori Y, Meltzer SJ.
Gastroenterology. 2009 May;136(5):1689-700.
The footprints of cancer development: Cancer biomarkers.
Ullah MF, Aatif M.
Cancer Treat Rev. 2009 May;35(3):193-200.
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.
Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Chan G, Kamath SG, Chen DT, Dressman H, Lancaster JM.
Gynecol Oncol. 2009 May;113(2):249-55.
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.
Roccaro AM, Sacco A, Chen C, Runnels J, Leleu X, Azab F, Azab AK, Jia X, Ngo HT, Melhem MR, Burwick N, Varticovski L, Novina CD,
Rollins BJ, Anderson KC, Ghobrial IM.
Blood. 2009 Apr 30;113(18):4391-402.
Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG.
Zhang B, Wang X, Wang Y.
J Exp Clin Cancer Res. 2009 Apr 28;28:56.
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y,
Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.
J Clin Oncol. 2009 Apr 20;27(12):2030-7.
miR-34a as part of the resistance network in chronic lymphocytic leukemia.
Zenz T, Mohr J, Eldering E, Kater AP, Bühler A, Kienle D, Winkler D, Dürig J, van Oers MH, Mertens D, Döhner H, Stilgenbauer S.
Blood. 2009 Apr 16;113(16):3801-8.
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.
Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD, Tibshirani R, Lossos IS.
Blood. 2009 Apr 16;113(16):3754-64.
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase
Itch for degradation.
Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W.
Blood. 2009 Apr 16;113(16):3744-53.
MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma.
Avissar M, Christensen BC, Kelsey KT, Marsit CJ.
Clin Cancer Res. 2009 Apr 15;15(8):2850-5.
MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.
Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA.
Cancer Res. 2009 Apr 15;69(8):3278-82.
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated
cerebellar neural precursors.
Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, Grundy R, Van Meter T, Rutka JT, Croce CM, Kenney
AM, Taylor MD.
Cancer Res. 2009 Apr 15;69(8):3249-55.
Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation
of Skp2 and MiR-222.
Hu L, Ibrahim S, Liu C, Skaar J, Pagano M, Karpatkin S.
Cancer Res. 2009 Apr 15;69(8):3374-81.
The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P.
Cancer Res. 2009 Apr 15;69(8):3356-63.
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling
pathways in Waldenstrom's macroglobulinemia.
Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R, Schop RF, Price-Troska T, Henderson K, Sacco A, Azab F,
Greipp P, Gertz M, Hayman S, Rajkumar SV, Carpten J, Chesi M, Barrett M, Stewart AK, Dogan A, Bergsagel PL, Ghobrial IM, Fonseca R.
Cancer Res. 2009 Apr 15;69(8):3579-88.
Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
Bornkamm GW.
Int J Cancer. 2009 Apr 15;124(8):1745-55.
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV.
Nature. 2009 Apr 9;458(7239):762-5.
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R.
Oncogene. 2009 Apr 9;28(14):1714-24.
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, Chen J, Rowley JD, Zeleznik-Le
NJ.
Blood. 2009 Apr 2;113(14):3314-22.
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J,
Garcia-Foncillas J.
Clin Cancer Res. 2009 Apr 1;15(7):2281-90.
[Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR]
Liu ZR, Chen XW, Qiao XH, Wang R, Xiang Z.
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Apr;29(4):751-3.
Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.
Yang S, Du J, Wang Z, Yan J, Yuan W, Zhang J, Zhu T.
Int J Biochem Cell Biol. 2009 Apr;41(4):853-61.
The impact of microRNAs on colorectal cancer.
Faber C, Kirchner T, Hlubek F.
Virchows Arch. 2009 Apr;454(4):359-67.
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C.
World J Surg. 2009 Apr;33(4):698-709.
MicroRNA and colorectal cancer.
Yang L, Belaguli N, Berger DH.
World J Surg. 2009 Apr;33(4):638-46.
Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.
Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P, van den Berg A.
Mod Pathol. 2009 Apr;22(4):547-55.
Over- and under-expressed microRNAs in human colorectal cancer.
Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M.
Int J Oncol. 2009 Apr;34(4):1069-75.
Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.
Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y.
J Gastroenterol Hepatol. 2009 Apr;24(4):652-7.
Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms.
Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN.
Biochim Biophys Acta. 2009 Apr;1792(4):341-52.
Suppression of cell growth and invasion by miR-205 in breast cancer.
Wu H, Zhu S, Mo YY.
Cell Res. 2009 Apr;19(4):439-48.
miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.
Gebeshuber CA, Zatloukal K, Martinez J.
EMBO Rep. 2009 Apr;10(4):400-5.
BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
Du J, Yang S, An D, Hu F, Yuan W, Zhai C, Zhu T.
Cell Res. 2009 Apr;19(4):487-96.
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.
O'Hara AJ, Chugh P, Wang L, Netto EM, Luz E, Harrington WJ, Dezube BJ, Damania B, Dittmer DP.
PLoS Pathog. 2009 Apr;5(4):e1000389.
Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true
rosettes.
Pfister S, Remke M, Castoldi M, Bai AH, Muckenthaler MU, Kulozik A, von Deimling A, Pscherer A, Lichter P, Korshunov A.
Acta Neuropathol. 2009 Apr;117(4):457-64.
A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer.
Waldman SA, Terzic A.
FEBS J. 2009 Apr;276(8):2157-64.
Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21
up-regulation in hepatocytes.
Vinciguerra M, Sgroi A, Veyrat-Durebex C, Rubbia-Brandt L, Buhler LH, Foti M.
Hepatology. 2009 Apr;49(4):1176-84.
MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human
hepatocellular carcinoma.
Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, Sun Z, Wei L, Zheng X.
Hepatology. 2009 Apr;49(4):1194-202.
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia.
Rainer J, Ploner C, Jesacher S, Ploner A, Eduardoff M, Mansha M, Wasim M, Panzer-Grümayer R, Trajanoski Z, Niederegger H, Kofler R.
Leukemia. 2009 Apr;23(4):746-52.
Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S.
Hepatology. 2009 Apr;49(4):1098-112.
MiRNAs and cancer.
Visone R, Croce CM.
Am J Pathol. 2009 Apr;174(4):1131-8.
MicroRNAs: novel biomarkers for human cancer.
Bartels CL, Tsongalis GJ.
Clin Chem. 2009 Apr;55(4):623-31.
MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J.
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1559-65.
Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, Banner BF, Chen YT.
Am J Surg Pathol. 2009 Apr;33(4):572-82.
MicroRNAs--the micro steering wheel of tumour metastases.
Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA.
Nat Rev Cancer. 2009 Apr;9(4):293-302.
MicroRNAs: key players in carcinogenesis and novel therapeutic targets.
Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G.
Eur J Surg Oncol. 2009 Apr;35(4):339-47.
Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm.
Hussein K, Dralle W, Theophile K, Kreipe H, Bock O.
Ann Hematol. 2009 Apr;88(4):325-32.
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ.
Br J Cancer. 2009 Mar 24;100(6):1002-11.
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.
Malinge S, Izraeli S, Crispino JD.
Blood. 2009 Mar 19;113(12):2619-28.
Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression.
Peter ME.
Cell Cycle. 2009 Mar 15;8(6):843-52.
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG,
Zaffaroni N.
Cancer Res. 2009 Mar 15;69(6):2287-95.
miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M, Manara E, Baron E, Basso G.
Cancer Res. 2009 Mar 15;69(6):2471-8.
The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.
Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, Zhou X, Jones PA.
Cancer Res. 2009 Mar 15;69(6):2623-9.
microRNA-205 regulates HER3 in human breast cancer.
Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Ménard S, Croce CM, Tagliabue E.
Cancer Res. 2009 Mar 15;69(6):2195-200.
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.
Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M, Baba H.
Clin Cancer Res. 2009 Mar 15;15(6):1915-22.
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Chung TK, Cheung TH, Huen NY, Wong KW, Lo KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, Yu MY, To KF, Mok SC, Wang VW,
Li C, Cheung AY, Doran G, Birrer MJ, Smith DI, Wong YF.
Int J Cancer. 2009 Mar 15;124(6):1358-65.
let-7 Overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in
primary fibroblasts.
Legesse-Miller A, Elemento O, Pfau SJ, Forman JJ, Tavazoie S, Coller HA.
J Biol Chem. 2009 Mar 13;284(11):6605-9.
Role of miR-143 targeting KRAS in colorectal tumorigenesis.
Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J,
Zhang CY.
Oncogene. 2009 Mar 12;28(10):1385-92.
Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
Roman-Gomez J, Agirre X, Jiménez-Velasco A, Arqueros V, Vilas-Zornoza A, Rodriguez-Otero P, Martin-Subero I, Garate L, Cordeu L,
San José-Eneriz E, Martin V, Castillejo JA, Bandrés E, Calasanz MJ, Siebert R, Heiniger A, Torres A, Prosper F.
J Clin Oncol. 2009 Mar 10;27(8):1316-22.
The insulin receptor substrate-1: a biomarker for cancer?
Baserga R.
Exp Cell Res. 2009 Mar 10;315(5):727-32.
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X.
Cancer Lett. 2009 Mar 8;275(1):44-53.
Molecular assays for the detection of microRNAs in prostate cancer.
Siva AC, Nelson LJ, Fleischer CL, Majlessi M, Becker MM, Vessella RL, Reynolds MA.
Mol Cancer. 2009 Mar 6;8:17.
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells.
Xia H, Qi Y, Ng SS, Chen X, Chen S, Fang M, Li D, Zhao Y, Ge R, Li G, Chen Y, He ML, Kung HF, Lai L, Lin MC.
Biochem Biophys Res Commun. 2009 Mar 6;380(2):205-10.
p53 represses c-Myc through induction of the tumor suppressor miR-145.
Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY.
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12.
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.
Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, Thomas-Tikhonenko A,
Mendell JT.
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3384-9.
MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.
Wang X, Gocek E, Liu CG, Studzinski GP.
Cell Cycle. 2009 Mar 1;8(5):736-41.
MiR-34, SIRT1 and p53: the feedback loop.
Yamakuchi M, Lowenstein CJ.
Cell Cycle. 2009 Mar 1;8(5):712-5.
Cell cycle arrest or apoptosis by p53: are microRNAs-192/215 and -34 making the decision?
Georges SA, Chau BN, Braun CJ, Zhang X, Dobbelstein M.
Cell Cycle. 2009 Mar 1;8(5):680-1.
MicroRNA-mediated regulation of Ubc9 expression in cancer cells.
Wu F, Zhu S, Ding Y, Beck WT, Mo YY.
Clin Cancer Res. 2009 Mar 1;15(5):1550-7.
The role of microRNA in tumorigenesis: key players or innocent bystanders.
Sini RA, Trink B, Nissan A.
J Surg Oncol. 2009 Mar 1;99(3):135-6.
In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma.
Kim HJ, Chung JK, Hwang do W, Lee DS, Kim S.
Mol Imaging Biol. 2009 Mar-Apr;11(2):71-8.
Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either
Intensity-modulated Radiation Therapy (IMRT), or Conventional Radiation Therapy (RT).
Ahmed FE, Vos PW, Jeffries C, Wiley JE, Weidner DA, Mota H, Bonnerup C, Sibata C, Allison RR.
Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):109-27.
[Time course of let-7a expression in the cell cycle of human cervical carcinoma HeLa cells]
Zhou JY, Ma WL, Yu HL, Xiao WW, Zheng WL.
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Mar;29(3):442-5.
Molecular signatures in acute myeloid leukemia.
Mrózek K, Radmacher MD, Bloomfield CD, Marcucci G.
Curr Opin Hematol. 2009 Mar;16(2):64-9.
Chronic lymphocytic leukemia and 13q14: miRs and more.
Mertens D, Philippen A, Ruppel M, Allegra D, Bhattacharya N, Tschuch C, Wolf S, Idler I, Zenz T, Stilgenbauer S.
Leuk Lymphoma. 2009 Mar;50(3):502-5.
MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J.
Leuk Lymphoma. 2009 Mar;50(3):506-9.
New insight into the role of miRNAs in leukemia.
Zhang H, Chen Y.
Sci China C Life Sci. 2009 Mar;52(3):224-31.
[MicroRNA and chromosomal translocations in hematologic malignancies]
Bousquet M, Dastugue N, Brousset P.
Med Sci (Paris). 2009 Mar;25(3):229-31.
Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach.
Yang Y, Chaerkady R, Beer MA, Mendell JT, Pandey A.
Proteomics. 2009 Mar;9(5):1374-84.
Recent developments in testicular germ cell tumor research.
van de Geijn GJ, Hersmus R, Looijenga LH.
Birth Defects Res C Embryo Today. 2009 Mar;87(1):96-113.
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas.
Qian ZR, Asa SL, Siomi H, Siomi MC, Yoshimoto K, Yamada S, Wang EL, Rahman MM, Inoue H, Itakura M, Kudo E, Sano T.
Mod Pathol. 2009 Mar;22(3):431-41.
Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.
Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, You J, Hu XQ.
Oncol Rep. 2009 Mar;21(3):673-9.
RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer.
Zhang Q, Meng Y, Zhang L, Chen J, Zhu D.
Cell Res. 2009 Mar;19(3):348-57.
17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.
Dijkstra MK, van Lom K, Tielemans D, Elstrodt F, Langerak AW, van 't Veer MB, Jongen-Lavrencic M.
Leukemia. 2009 Mar;23(3):625-7.
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.
Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu
CG, Villanueva A, Capella G, Schwartz S Jr, Shiekhattar R, Esteller M.
Nat Genet. 2009 Mar;41(3):365-70.
MicroRNA profile analysis of human prostate cancers.
Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J.
Cancer Gene Ther. 2009 Mar;16(3):206-16.
Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke.
Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S.
FASEB J. 2009 Mar;23(3):806-12.
MicroRNA-143 as a tumor suppressor for bladder cancer.
Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C, Huang L.
J Urol. 2009 Mar;181(3):1372-80.
HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.
Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, Nakao M.
Am J Pathol. 2009 Mar;174(3):854-68.
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ,
Schlecht NF.
Am J Pathol. 2009 Mar;174(3):736-45.
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7.
Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ.
J Biol Chem. 2009 Feb 27;284(9):5731-41.
Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
Sun R, Fu X, Li Y, Xie Y, Mao Y.
BMC Genomics. 2009 Feb 26;10:93.
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma.
Uziel T, Karginov FV, Xie S, Parker JS, Wang YD, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G, Roussel MF.
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2812-7.
The context and potential of epigenetics in oncology.
Lopez J, Percharde M, Coley HM, Webb A, Crook T.
Br J Cancer. 2009 Feb 24;100(4):571-7.
MicroRNAs and cancer: short RNAs go a long way.
Ventura A, Jacks T.
Cell. 2009 Feb 20;136(4):586-91.
Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.
Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM, Minn AJ, Rosner MR.
EMBO J. 2009 Feb 18;28(4):347-58.
MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium.
Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, Lu J, Liu G, Zhang X, Bowers J, Vaziri C, Ott K, Sensinger K,
Collins JJ, Brody JS, Getts R, Lenburg ME, Spira A.
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2319-24.
Mature miR-184 and squamous cell carcinoma of the tongue.
Wong TS, Ho WK, Chan JY, Ng RW, Wei WI.
ScientificWorldJournal. 2009 Feb 15;9:130-2.
Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR.
Cancer Res. 2009 Feb 15;69(4):1279-83.
Repressing the repressor: a new mode of MYC action in lymphomagenesis.
Sander S, Bullinger L, Wirth T.
Cell Cycle. 2009 Feb 15;8(4):556-9.
Uncovering growth-suppressive MicroRNAs in lung cancer.
Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H, DiRenzo J, Korc M, Cole CN,
Bak M, Kauppinen S, Dmitrovsky E.
Clin Cancer Res. 2009 Feb 15;15(4):1177-83.
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen
resistance.
Xin F, Li M, Balch C, Thomson M, Fan M, Liu Y, Hammond SM, Kim S, Nephew KP.
Bioinformatics. 2009 Feb 15;25(4):430-4.
Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.
Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G.
Biochem Biophys Res Commun. 2009 Feb 13;379(3):726-31.
MicroRNA-dependent regulation of cKit in cutaneous melanoma.
Igoucheva O, Alexeev V.
Biochem Biophys Res Commun. 2009 Feb 13;379(3):790-4.
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J,
Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E.
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9.
Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation.
Rahman MM, Qian ZR, Wang EL, Sultana R, Kudo E, Nakasono M, Hayashi T, Kakiuchi S, Sano T.
Br J Cancer. 2009 Feb 10;100(3):501-10.
MicroRNAs in the pathogenesis of neuroblastoma.
Schulte JH, Horn S, Schlierf S, Schramm A, Heukamp LC, Christiansen H, Buettner R, Berwanger B, Eggert A.
Cancer Lett. 2009 Feb 8;274(1):10-5.
A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT.
Miura N, Sato R, Tsukamoto T, Shimizu M, Kabashima H, Takeda M, Takahashi S, Harada T, West JE, Drabkin H, Mejia JE, Shiota G,
Murawaki Y, Virmani A, Gazdar AF, Oshimura M, Hasegawa J.
BMC Mol Biol. 2009 Feb 2;10:5.
How epigenetics can explain human metastasis: a new role for microRNAs.
Lujambio A, Esteller M.
Cell Cycle. 2009 Feb 1;8(3):377-82.
MicroRNA regulation of DNA repair gene expression in hypoxic stress.
Crosby ME, Kulshreshtha R, Ivan M, Glazer PM.
Cancer Res. 2009 Feb 1;69(3):1221-9.
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
Li Z, Luo RT, Mi S, Sun M, Chen P, Bao J, Neilly MB, Jayathilaka N, Johnson DS, Wang L, Lavau C, Zhang Y, Tseng C, Zhang X, Wang J,
Yu J, Yang H, Wang SM, Rowley JD, Chen J, Thirman MJ.
Cancer Res. 2009 Feb 1;69(3):1109-16.
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM.
Cancer Res. 2009 Feb 1;69(3):1135-42.
MicroRNA profiling in human medulloblastoma.
Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, Di Rocco C, Riccardi R, Giangaspero F, Farcomeni A, Nofroni I,
Laneve P, Gioia U, Caffarelli E, Bozzoni I, Screpanti I, Gulino A.
Int J Cancer. 2009 Feb 1;124(3):568-77.
Real-time PCR analysis of micro-RNA expression in ionizing radiation-treated cells.
Chaudhry MA.
Cancer Biother Radiopharm. 2009 Feb;24(1):49-56.
MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells.
Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH.
Biomed Environ Sci. 2009 Feb;22(1):14-21.
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.
Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A.
Cancer Biol Ther. 2009 Feb;8(4):340-6.
Study of MicroRNA expression profiles of esophageal cancer.
Mishima T, Akagi I, Miyashita M, Ishibashi O, Mizuguchi Y, Tajiri T, Takizawa T.
J Nippon Med Sch. 2009 Feb;76(1):43.
The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N, Maher SG, Reynolds JV.
Biol Rev Camb Philos Soc. 2009 Feb;84(1):55-71.
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ, van den Berg A.
Neoplasia. 2009 Feb;11(2):167-76.
Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma.
Flavin RJ, Smyth PC, Laios A, O'Toole SA, Barrett C, Finn SP, Russell S, Ring M, Denning KM, Li J, Aherne ST, Sammarae DA, Aziz NA,
Alhadi A, Sheppard BL, Lao K, Sheils OM, O'Leary JJ.
Mod Pathol. 2009 Feb;22(2):197-205.
Evolution of microRNA expression during human bronchial squamous carcinogenesis.
Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A, Sculier JP.
Eur Respir J. 2009 Feb;33(2):352-9.
microRNA expression profile in undifferentiated gastric cancer.
Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y, Ogawa R, Harata K, Fujii Y.
Int J Oncol. 2009 Feb;34(2):537-42.
MicroRNAs in the ontogeny of leukemias and lymphomas.
Fabbri M, Croce CM, Calin GA.
Leuk Lymphoma. 2009 Feb;50(2):160-70.
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.
Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, Li L, Huang DD, Ding J, Shen F, Zhou WP, Wu MC, Wang HY.
J Hepatol. 2009 Feb;50(2):358-69.
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
Schotte D, Chau JC, Sylvester G, Liu G, Chen C, van der Velden VH, Broekhuis MJ, Peters TC, Pieters R, den Boer ML.
Leukemia. 2009 Feb;23(2):313-22.
MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.
Gastroenterology. 2009 Feb;136(2):683-93.
Detection of miR-106a in gastric carcinoma and its clinical significance.
Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, Li D, Zhong J.
Clin Chim Acta. 2009 Feb;400(1-2):97-102.
Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
Wu W, Lin Z, Zhuang Z, Liang X.
Eur J Cancer Prev. 2009 Feb;18(1):50-5.
miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
Schaar DG, Medina DJ, Moore DF, Strair RK, Ting Y.
Exp Hematol. 2009 Feb;37(2):245-55.
An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.
Selcuklu SD, Yakicier MC, Erson AE.
Cancer Genet Cytogenet. 2009 Feb;189(1):15-23.
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
Liu T, Tang H, Lang Y, Liu M, Li X.
Cancer Lett. 2009 Jan 18;273(2):233-42.
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid
peroxidation.
Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, Dianzani MU, Negrini M, Barrera G.
Free Radic Biol Med. 2009 Jan 15;46(2):282-8.
Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.
Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS.
Cancer Res. 2009 Jan 15;69(2):709-17.
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.
Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K.
Blood. 2009 Jan 8;113(2):396-402.
Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic
leukemia.
Saumet A, Vetter G, Bouttier M, Portales-Casamar E, Wasserman WW, Maurin T, Mari B, Barbry P, Vallar L, Friederich E, Arar K,
Cassinat B, Chomienne C, Lecellier CH.
Blood. 2009 Jan 8;113(2):412-21.
miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression.
Pickering MT, Stadler BM, Kowalik TF.
Oncogene. 2009 Jan 8;28(1):140-5.
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation.
Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D'Esposito M, Di Lauro R, Verde P.
Oncogene. 2009 Jan 8;28(1):73-84.
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma.
Ciarpica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R, Giordano A.
Cell Cycle. 2009 Jan 1;8(1):172-5.
Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA.
Yadav D, Ngolab J, Lim RS, Krishnamurthy S, Bui JD.
J Immunol. 2009 Jan 1;182(1):39-43.
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.
Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, Kocherginsky M, Parker JS, Chung CH, Rosner MR.
Cancer Res. 2009 Jan 1;69(1):65-74.
MicroRNA expression profiling in bone marrow: implications in hematological malignancies.
Costa A, Osório C, Dias S.
Biotechnol J. 2009 Jan;4(1):88-97.
MicroRNA and cancer--focus on apoptosis.
Wang Y, Lee CG.
J Cell Mol Med. 2009 Jan;13(1):12-23.
miR-21: a small multi-faceted RNA.
Krichevsky AM, Gabriely G.
J Cell Mol Med. 2009 Jan;13(1):39-53.
MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a.
Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, Liu W, Qiang B, Zhao J, Yuan J, Peng X.
J Mol Med. 2009 Jan;87(1):43-51.
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G.
Stem Cells. 2009 Jan;27(1):40-8.
Current progress in epigenetic research for hepatocarcinomagenesis.
Huang J.
Sci China C Life Sci. 2009 Jan;52(1):31-42.
Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1
(NAIP) in glioblastoma multiforme (GBM).
Lukiw WJ, Cui JG, Li YY, Culicchia F.
J Neurooncol. 2009 Jan;91(1):27-32.
Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
Ju X, Li D, Shi Q, Hou H, Sun N, Shen B.
Pediatr Hematol Oncol. 2009 Jan;26(1):1-10.
MicroRNAs and cancer-the search begins!
Oulas A, Reczko M, Poirazi P.
IEEE Trans Inf Technol Biomed. 2009 Jan;13(1):67-77.
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer.
Rosell R, Wei J, Taron M.
Clin Lung Cancer. 2009 Jan;10(1):8-9.
Exosomal microRNA: a diagnostic marker for lung cancer.
Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH.
Clin Lung Cancer. 2009 Jan;10(1):42-6.
High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.
Ann Surg Oncol. 2009 Jan;16(1):208-19.
Oncomirs: from tumor biology to molecularly targeted anticancer strategies.
Mocellin S, Pasquali S, Pilati P.
Mini Rev Med Chem. 2009 Jan;9(1):70-80.
Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates
with a transformed phenotype in breast cancer cells.
Adams BD, Claffey KP, White BA.
Endocrinology. 2009 Jan;150(1):14-23.
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis.
Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY, Ma X.
Childs Nerv Syst. 2009 Jan;25(1):13-20.
MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma.
Jung I, Aguiar RC.
Br J Haematol. 2009 Jan;144(1):138-40.
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9).
Albano F, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G.
Br J Haematol. 2009 Jan;144(2):271-3.
Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin.
Bu Y, Lu C, Bian C, Wang J, Li J, Zhang B, Li Z, Brewer G, Zhao RC.
Oncol Rep. 2009 Jan;21(1):13-7.
Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic
leukemia.
Nagel S, Venturini L, Przybylski GK, Grabarczyk P, Schmidt CA, Meyer C, Drexler HG, Macleod RA, Scherr M.
Leuk Lymphoma. 2009 Jan;50(1):101-8.
MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia.
Chaubey A, Karanti S, Rai D, Oh T, Adhvaryu SG, Aguiar RC.
Leukemia. 2009 Jan;23(1):186-8.
MicroRNAs differentially expressed in ACTH-secreting pituitary tumors.
Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, Silva WA Jr, Moreira AC, Castro M.
J Clin Endocrinol Metab. 2009 Jan;94(1):320-3.
miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
Park SY, Lee JH, Ha M, Nam JW, Kim VN.
Nat Struct Mol Biol. 2009 Jan;16(1):23-9.
MicroRNA expression profiles in thyroid tumors.
Nikiforova MN, Chiosea SI, Nikiforov YE.
Endocr Pathol. 2009 Summer;20(2):85-91.
Modulation of microRNA associated with ovarian cancer cells by genistein.
Parker LP, Taylor DD, Kesterson J, Metzinger DS, Gercel-Taylor C.
Eur J Gynaecol Oncol. 2009;30(6):616-21.
MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer.
Boni V, Bandres E, Zarate R, Colucci G, Maiello E, Garcia-Foncillas J.
Oncology. 2009;77 Suppl 1:75-89.
MicroRNA expression profiling of male breast cancer.
Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A.
Breast Cancer Res. 2009;11(4):R58.
mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen
receptor-negative breast cancer.
Cheng C, Fu X, Alves P, Gerstein M.
Genome Biol. 2009;10(9):R90.
MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser
capture microdissection.
Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE.
Clin Exp Metastasis. 2009;26(8):965-79.
miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
Wu X, Wu S, Tong L, Luan T, Lin L, Lu S, Zhao W, Ma Q, Liu H, Zhong Z.
Scand J Gastroenterol. 2009;44(11):1332-9.
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ.
Breast Cancer Res. 2009;11(3):R27.
microRNAs mature with help from cancer biology.
Paroo Z, Pertsemlidis A.
Genome Biol. 2009;10(7):310.
Emerging roles of microRNAs in the molecular responses to hypoxia.
Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M.
Curr Pharm Des. 2009;15(33):3861-6.
microRNAs in gliomas: small regulators of a big problem.
Silber J, James CD, Hodgson JG.
Neuromolecular Med. 2009;11(3):208-22.
In this issue: on miRNAs connecting cancer with inflammation and novel concepts in immunology and vaccine design.
Bot A.
Int Rev Immunol. 2009;28(5):261-3.
miR-155: on the crosstalk between inflammation and cancer.
Tili E, Croce CM, Michaille JJ.
Int Rev Immunol. 2009;28(5):264-84.
[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma]
Slabý O, Svoboda M, Michálek J, Vyzula R.
Klin Onkol. 2009;22(5):202-9.
Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.
Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra A.
Pancreatology. 2009;9(3):293-301.
MicroRNAs in Cancer.
Garzon R, Calin GA, Croce CM.
Annu Rev Med. 2009;60:167-79.
The clinicopathological relevance of microRNA in normal and malignant haematopoiesis.
Bryant A, Lutherborrow M, Ma D.
Pathology. 2009;41(3):204-13.
Prediction of breast cancer metastasis by genomic profiling: where do we stand?
Pfeffer U, Romeo F, Noonan DM, Albini A.
Clin Exp Metastasis. 2009;26(6):547-58.
Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.
Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T, Si J.
J Gastroenterol. 2009;44(6):556-61.
Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.
Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M.
PLoS One. 2009;4(4):e5311.
Decreased expression of microRNA-143 and -145 in human gastric cancers.
Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y.
Oncology. 2009;77(1):12-21.
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.
Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M.
PLoS One. 2009;4(5):e5532.
MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.
Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH, Ma X.
Cell Physiol Biochem. 2009;23(4-6):347-58.
MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.
Seux M, Iovanna J, Dagorn JC, Dusetti NJ.
Pancreatology. 2009;9(1-2):66-72.
MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.
Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L, Esposito S, Gargiulo S, Fattet S,
Donofrio V, Cinalli G, Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD, Iolascon A, Zollo M.
PLoS One. 2009;4(3):e4998.
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM,
Kalland KH.
PLoS One. 2009;4(3):e4687.
MicroRNAs in cancer.
Lee YS, Dutta A.
Annu Rev Pathol. 2009;4:199-227.
MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.
Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, Hofman P.
Curr Med Chem. 2009;16(9):1047-61.
Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.
Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY, Sun XF.
Dis Markers. 2009;26(1):27-34.
MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.
Stallings RL.
Curr Pharm Des. 2009;15(4):456-62.
MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis.
Navarro A, Marrades RM, Viñolas N, Quera A, Agustí C, Huerta A, Ramirez J, Torres A, Monzo M.
Oncology. 2009;76(3):162-9.
The role of microRNAs in gastrointestinal cancers.
Saito Y, Suzuki H, Hibi T.
J Gastroenterol. 2009;44 Suppl 19:18-22.